STEPHANIE SPARKES

Allopathic & Osteopathic Physicians|Family Medicine SAHUARITA, AZ NPI 1003478728

General Payments — all program years on this page

$1,104.74

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 49
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $311.23 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $311.2317

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $63.245
2022 $60.404
2023 $669.8723
2024 $311.2317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086219107 Bayer Healthcare Pharmaceuticals Inc. $15.78 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096596626 Novo Nordisk Inc $16.22 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096832372 Novo Nordisk Inc $16.78 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097575731 Novo Nordisk Inc $15.23 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097661957 Novo Nordisk Inc $15.78 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097738621 Novo Nordisk Inc $18.53 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105612951 AstraZeneca Pharmaceuticals LP $14.94 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106144320 ABBVIE INC. $23.09 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116232005 GlaxoSmithKline, LLC. $16.43 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116476784 GlaxoSmithKline, LLC. $13.33 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117690324 Amgen Inc. $16.05 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131278448 PFIZER INC. $13.81 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131737888 PFIZER INC. $19.66 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135386491 Lilly USA, LLC $22.30 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139324680 Astellas Pharma US Inc $21.16 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139335672 Astellas Pharma US Inc $28.06 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148922623 Sumitomo Pharma America, Inc. $24.08 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.